Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography

Matsumoto, Mayumi; Io, Hiroaki; Furukawa, Masashi; Okumura, K; Masuda, Atsumi; Seto, Takuya; Takagi, Miyuki; Sato, Michiko; Nagahama, Lili; Omote, Keisuke; Hisada, Atsuko; Horikoshi, Satoshi; Tomino, Yasuhiko

doi:10.5301/jn.5000066

Cited by 29 publications

(32 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nakatani et al [136] showed that the plasma ANP level is one of the most important risk predictors of LV hypertrophy. The correlation between plasma ANP and LV mass was observed previously [124,125,134,135]. It has been hypothesized that left atrium (LA) size represents the integration of LV diastolic performance (compliance) over time.…”

Section: Peritoneal Dialysis: Animal Model and Patientsmentioning

confidence: 53%

“…We have examined cardiovascular function in CKD patients using ultrasonography [124,125,134,135]. Nakatani et al [136] showed that the plasma ANP level is one of the most important risk predictors of LV hypertrophy.…”

Section: Peritoneal Dialysis: Animal Model and Patientsmentioning

confidence: 99%

“…Echocardiography is widely used for the evaluation of cardiac structure and function [124]. The prognostic value of assessment of the left cardiac atrium (LA) size in PD patients is still unclear.…”

Section: Peritoneal Dialysis: Animal Model and Patientsmentioning

confidence: 99%

See 2 more Smart Citations

Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data

Tomino

2014

Kidney Blood Press Res

Self Cite

439

View full text Add to dashboard Cite

Chronic kidney disease (CKD) is a worldwide public health problem that affects millions of people from all racial and ethnic groups. At end of 2013, over 300,000 Japanese patients had maintenance dialysis therapy (JSDT). In Japan, the major causes of end stage kidney disease (ESKD) are chronic glomerulonephritis (particularly IgA nephropathy), type 2 diabetic nephropathy, and hypertensive nephrosclerosis. Hypertension is a major factor driving the progression of CKD to ESKD. Since many features of the pathogenesis of IgA nephropathy are still obscure, specific treatment is not yet available. However, efforts by investigators around the world have gradually clarified different aspects of the pathogenesis and treatment of IgA nephropathy. Today, around half of all diabetic patients in Japan receive medical treatment. Type 2 diabetic nephropathy is one of the major long-term microvascular complications occurring in nearly 40% of Japanese diabetic patients. The pathogenesis of diabetic nephropathy involves both genetic and environmental factors. However, the candidate genes related to the initiation and progression of the disorder are still obscure in patients with diabetic nephropathy. Regarding environmental factors, the toxicity of persistent hyperglycemia, reactive oxygen species, systemic and/or glomerular hypertension, dyslipidemia and complement are considered to play an important role. The first part of this review covers the pathogenesis of IgA nephropathy and type 2 diabetic nephropathy, and combines the clinicopathological findings in patients with our research on the ddY and KKA-y mouse models (spontaneous animal models for IgA nephropathy and diabetic nephropathy, respectively). In Japan, the major renal replacement therapies (RRT) are peritoneal dialysis (PD) and hemodialysis (HD). The second part of this review focuses on PD and HD. Based on our research findings from patients and as well as from animal models, we discuss strategies for the management of patients on PD and HD. i 2015 S. Karger AG, Basel

show abstract

Section: Peritoneal Dialysis: Animal Model and Patientsmentioning

confidence: 53%

Section: Peritoneal Dialysis: Animal Model and Patientsmentioning

confidence: 99%

See 1 more Smart Citation

Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data

Tomino

2014

Kidney Blood Press Res

Self Cite

439

View full text Add to dashboard Cite

show abstract

“…Echocardiographic examinations were performed in all patients as previously described [4,11] using a Toshiba ultrasound system (model 260 SS-A equipped with a 2.5-MHz phased array transducer; Tokyo, Japan). All examinations were performed in the left lateral recumbent position, and all data were evaluated according to the guidelines of the American Society of Echocardiography [12].…”

Section: Methodsmentioning

confidence: 99%

“…The peak early diastolic left ventricular filling velocity/atrial filling velocity ratio (E/A) and deceleration time (DcT), which are diastolic dysfunction predictors, can be measured using echocardiography. Matsumoto et al [4] demonstrated the risk factors associated with an increased left ventricular mass index in patients with pre-HD using echocardiography.…”

Section: Introductionmentioning

confidence: 99%

Effects of Cardiac Function with Postoperative Arteriovenous Fistula Blood Flow in Patients with Hemodialysis

Wakabayashi

Io²,

Nakata³

et al. 2017

Blood Purif

Self Cite

View full text Add to dashboard Cite

Background/Aims: This study was aimed at evaluating the effect of cardiac function with postoperative arteriovenous fistula (AVF) blood flow in hemodialysis (HD) patients. Methods: A total of 45 HD patients were examined at the Juntendo University Hospital. The AVF blood flow was measured using ultrasonography, and the cardiac function was measured using echocardiography. Correlation between these parameters and the rate of change in body weight (BW) was analyzed. Results: The number of postoperative days significantly correlated with the AVF blood flow, and it positively correlated with the stroke volume (SV). The postoperative AVF blood flow in patients with reduced ejection fraction (EF) was lower than that in patients with normal EF. The rate of change of BW negatively correlated with that of SV, positively correlated with cardiac output (CO), and positively correlated with CO in patients with an AVF blood flow of more than 1,000 mL/min. Conclusion: It appears that the cardiac function can be improved by controlling the BW even in patients with high AVF blood flow.

show abstract

Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1–3) patients

Nohara

Matsumoto

et al. 2015

Clin Exp Nephrol

Self Cite

View full text Add to dashboard Cite

show abstract

Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography

Abstract: It is important to treat hypertension and anemia to prevent LVH in CKD patients. These findings have some therapeutic implications for treatment strategies for predialysis patients.

Cited by 29 publications

References 29 publications

Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data

Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data

Effects of Cardiac Function with Postoperative Arteriovenous Fistula Blood Flow in Patients with Hemodialysis

Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1–3) patients

Contact Info

Product

Resources

About